ES2104130T3 - Adn hibrido, que codifica una subunidad de una toxina bacteriana con una hemolisina. - Google Patents

Adn hibrido, que codifica una subunidad de una toxina bacteriana con una hemolisina.

Info

Publication number
ES2104130T3
ES2104130T3 ES93905242T ES93905242T ES2104130T3 ES 2104130 T3 ES2104130 T3 ES 2104130T3 ES 93905242 T ES93905242 T ES 93905242T ES 93905242 T ES93905242 T ES 93905242T ES 2104130 T3 ES2104130 T3 ES 2104130T3
Authority
ES
Spain
Prior art keywords
hemolysin
subunit
codes
hybrid dna
bacterial toxin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93905242T
Other languages
English (en)
Inventor
Himanshu Brahmbhatt
Guo-Fu Su
Jurgen Wehland
Kenneth N Timmis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Helmholtz Centre for Infection Research
Original Assignee
Helmholtz Centre for Infection Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Helmholtz Centre for Infection Research filed Critical Helmholtz Centre for Infection Research
Application granted granted Critical
Publication of ES2104130T3 publication Critical patent/ES2104130T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/25—Shigella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/61—Fusion polypeptide containing an enzyme fusion for detection (lacZ, luciferase)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)

Abstract

LA INVENCION SE REFIERE A UN DNA HIBRIDO CARACTERIZADO PORQUE LA ESTRUCTURA DNA QUE CODIFICA UNA SUBUNIDAD DE UNA TOXINA BACTERIAL, ESTA FUSIONADA CON UNA CODIFICACION H1YA (HEMOLISINA) DE ESTRUCTURA DNA O SU FRAGMENTO C-TERMINAL. SE DESCRIBEN TAMBIEN PLASMIDAS, ALARGAMIENTOS PRINCIPALES, OLIGOHIBRIDOPEPTIDOS Y VACUNAS OBTENIDAS MEDIANTE LA UTILIZACION DE LA MENCIONADA DNA HIBRIDA.
ES93905242T 1992-02-17 1993-02-12 Adn hibrido, que codifica una subunidad de una toxina bacteriana con una hemolisina. Expired - Lifetime ES2104130T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4204737 1992-02-17
DE4219696A DE4219696A1 (de) 1992-02-17 1992-06-16 Hybrid-dna, plasmide, oligohybridpeptid und impfstoff

Publications (1)

Publication Number Publication Date
ES2104130T3 true ES2104130T3 (es) 1997-10-01

Family

ID=25911935

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93905242T Expired - Lifetime ES2104130T3 (es) 1992-02-17 1993-02-12 Adn hibrido, que codifica una subunidad de una toxina bacteriana con una hemolisina.

Country Status (8)

Country Link
EP (1) EP0627006B1 (es)
JP (1) JPH07505052A (es)
AT (1) ATE152483T1 (es)
AU (1) AU672388B2 (es)
DE (2) DE4219696A1 (es)
DK (1) DK0627006T3 (es)
ES (1) ES2104130T3 (es)
WO (1) WO1993016186A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2766193B1 (fr) * 1997-07-18 2001-09-14 Inst Curie Polypeptide chimerique comprenant le fragment b de la toxine shiga et des peptides d'interet therapeutique
JP4820000B2 (ja) 1998-05-15 2011-11-24 アラン エム グリーン 免疫処置のためのベロ毒素ｂサブユニット
US6264087B1 (en) 1999-07-12 2001-07-24 Powermed, Inc. Expanding parallel jaw device for use with an electromechanical driver device
EP1057895A1 (de) * 1999-06-04 2000-12-06 Lohmann Animal Health GmbH & Co. KG Fusionsprotein das das Fragment B des Shigatoxins enthält, dieses enthaltende (Impf-)Stoffzusammensetzung und Verfahren zu dessen Herstellung

Also Published As

Publication number Publication date
ATE152483T1 (de) 1997-05-15
EP0627006A1 (de) 1994-12-07
DE59306342D1 (de) 1997-06-05
EP0627006B1 (de) 1997-05-02
JPH07505052A (ja) 1995-06-08
DE4219696A1 (de) 1993-08-19
AU3628293A (en) 1993-09-03
DK0627006T3 (da) 1997-11-03
WO1993016186A1 (de) 1993-08-19
AU672388B2 (en) 1996-10-03

Similar Documents

Publication Publication Date Title
DE69327534D1 (de) Impfstoffe gegen diphtherietoxin
PT948518E (pt) Molecula de acido nucleico isolada que codifica um antigenio associado ao cancro o proprio antigenio e suas utilizacoes
IT1149388B (it) Perfezionamento nei codificatori per codici di attivazione di messaggi trasmessi, in particolare per dispositivi cercapersone
ES2192561T3 (es) Adn que codifica el receptor ip de prostaglandina.
ES2127829T3 (es) Expresion de proteinas recombinantes fusionadas en bacterias atenuadas.
EA199800946A1 (ru) Концентрированный препарат антител
ES2153037T3 (es) Lacasas purificadas de scytalidium y acidos nucleicos que las codifican.
EA199700272A1 (ru) Вакцины, содержащие сапонин и стерин
AR243234A1 (es) Un gen quimerico modificado que codifica una proteina insecticida de bacillus thuringiensis,un vector que lo contiene, y un metodo para mejorar la expresion de un gen heterologo.
DK0524205T3 (da) Levende vacciner
IL129686A (en) Method for producing recombinant virus
ES2123482T3 (es) Receptor de estrogeno.
HUT77049A (hu) Katepszin-02-fehérjék, -nukleinsavak és -ellenanyagok
ES2120052T3 (es) Receptor de prostaglandina fp y dna que lo codifica.
ES2151560T3 (es) Adn codificador de una subunidad alfa-1e de canales de calcio humanos.
ES2186671T3 (es) Adn del sitio de integracion del virus asociado a adenovirus humano y usos del mismo.
ES2044959T3 (es) Exotoxina de tos ferina modificada.
DK0538341T3 (da) EHV-4-gycoproteinvaccine.
AR246310A1 (es) Procedimiento para la preparacion de la cadena alfa- del receptor de la interleucina 5 humana, o partes del mismo, secuencia del adn, vector y celula hospedante.
ES2171549T3 (es) Or-1 en receptor huerfano perteneciente a la familia de receptores nucleares.
EP0785716A4 (en) CYTOKIN DESCRIBED AS LERK6
ES2060974T3 (es) Cepas de levadura para la produccion de proteinas heterologas maduras, en particular de hirudina.
ES2133820T3 (es) Marcador para patologias que implican una reaccion autoinmune y/o para enfermedades inflamatorias.
ES2005757A6 (es) Un metodo para producir proteinas de fusion por medios recombinantes.
DK0627006T3 (da) Hybrid-DNA, der koder for en underenhed af et bakterietoxin med et hæmolysin.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 627006

Country of ref document: ES